Stifel lowered the firm’s price target on Danaher (DHR) to $260 from $265 and keeps a Hold rating on the shares. Danaher ...

Stifel analyst Chris O’Cull raised the firm’s price target on Brinker (EAT) to $200 from $170 and keeps a Buy rating on the shares after what the firm calls “another stellar quarter.” The results are ...

Stifel analysts adjusted their outlook on Intel stock (NASDAQ:INTC), lowering the price target to $21.00 from the previous $25.00, while keeping a Hold rating on the shares. The revision follows Intel ...

While total segment revenue declined 6.6% year-over-year due to weak truckload (TL) demand and lower rates, gross margins ...

Fintel reports that on January 30, 2025, Stifel upgraded their outlook for Edwards Lifesciences (NYSE:EW) from Hold to Buy.

The firm’s CEO cited a “very competitive” recruiting market in 2024, but forecasts a better 2025 as longer-term efforts pay ...

In a report released today, Cole McGill from Stifel Nicolaus maintained a Buy rating on Hudbay Minerals (HBM – Research Report), with a price ...

Edwards Lifesciences (NYSE: EW) stock rises after Stifel upgrades to Buy, citing potential for TAVR growth acceleration in 2025. Read more here.

The natural beauty of West Virginia will be celebrated both musically and visually in the Wheeling Symphony Orchestra’s upcoming performance, “Nature. Beauty.” Set for 2 p.m., Feb. 8, at the Capitol ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $125.6, a high estimate of $135.00, and a low estimate of $115.00. This upward trend is evident, ...